1.
Wadden T, Auerbach P, Endahl L, Tronieri JS, Skovgaard D, Sugimoto D, et al. OUTCOMES IN EARLY RESPONDERS ACHIEVING ≥5% WEIGHT LOSS AT 16 WEEKS WITH LIRAGLUTIDE 3.0 mg AS AN ADJUNCT TO INTENSIVE BEHAVIOUR THERAPY (IBT) IN INDIVIDUALS WITH OBESITY IN THE SCALE IBT TRIAL. J ASEAN Fed Endocr Soc [Internet]. 2022 Jun. 8 [cited 2024 Nov. 21];34(2):48. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/2021